Skip to main content

Advertisement

Log in

Understanding Patients’ Perspectives and Educational Needs by Type of Osteoporosis in Men and Women and People with Glucocorticosteroid-Induced Osteoporosis: A Qualitative Study to Improve Disease Management

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

The aim of the study was to investigate similarities and differences in health beliefs, experiences and educational needs by type of osteoporosis (OP), particularly in people with glucocorticoid-induced OP (GIOP) and men. A qualitative study was conducted via focus groups involving post-menopausal women with or without osteoporotic fractures, osteoporotic men and people with GIOP. Fifty-three participants were included in eight groups. A wide range of health beliefs was found for all types of OP. Osteoporosis was considered a natural consequence of ageing except in men or conversely a serious disease associated with risk of new fractures and disability. GIOP patients had heterogeneous knowledge of OP and reported fewer prevention behaviours, and their quality of life was affected by the causal illness. Men had difficulties coping with the loss of their functional abilities and felt that OP was a “women’s” disease. Beliefs about treatments ranged from confidence to fear of adverse effects or doubt about efficacy in all types of OP. Participants were interested in physical activity, fall prevention and diet, and preferred group sessions. GIOP patients and men had an interest in face-to-face education. Men were also interested in brief information including via the Internet. Patients’ beliefs about OP differed by type of OP. Specific populations such as men or people with GIOP need particular care owing to experiences and needs. Offering group sessions in educational interventions is of interest to allow for sharing experiences and also face-to-face education for men and GIOP patients or the Internet for men.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wade SW, Strader C, Fitzpatrick LA et al (2014) Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos 9:182. https://doi.org/10.1007/s11657-014-0182-3

    Article  CAS  PubMed  Google Scholar 

  2. Alswat KA (2017) Gender disparities in osteoporosis. J Clin Med Res 9:382–387. https://doi.org/10.14740/jocmr2970w

    Article  PubMed  PubMed Central  Google Scholar 

  3. Qaseem A, Forciea MA, McLean RM et al (2017) Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians. Ann Intern Med 166:818–839. https://doi.org/10.7326/M15-1361

    Article  PubMed  Google Scholar 

  4. Briot K, Roux C (2015) Glucocorticoid-induced osteoporosis. RMD Open 1:e000014. https://doi.org/10.1136/rmdopen-2014-000014

    Article  PubMed  PubMed Central  Google Scholar 

  5. Silverman S, Curtis J, Saag K et al (2015) International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 26:419–420. https://doi.org/10.1007/s00198-014-2883-2

    Article  CAS  Google Scholar 

  6. Kanis JA, Cooper C, Rizzoli R et al (2018) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. https://doi.org/10.1007/s00198-018-4704-5

    Article  Google Scholar 

  7. Lems WF, Dreinhöfer KE, Bischoff-Ferrari H et al (2017) EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures. Ann Rheum Dis 76:802–810. https://doi.org/10.1136/annrheumdis-2016-210289

    Article  CAS  PubMed  Google Scholar 

  8. Briot K, Roux C, Thomas T et al (2018) 2018 update of French recommendations on the management of postmenopausal osteoporosis. Jt Bone Spine Rev Rhum 85:519–530. https://doi.org/10.1016/j.jbspin.2018.02.009

    Article  Google Scholar 

  9. Buckley L, Guyatt G, Fink HA et al (2017) 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 69:1095–1110. https://doi.org/10.1002/acr.23279

    Article  Google Scholar 

  10. Briot K, Cortet B, Roux C et al (2014) 2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis. Jt Bone Spine Rev Rhum 81:493–501. https://doi.org/10.1016/j.jbspin.2014.10.001

    Article  Google Scholar 

  11. Huas D, Debiais F, Blotman F et al (2010) Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment. BMC Womens Health 10:26. https://doi.org/10.1186/1472-6874-10-26

    Article  PubMed  PubMed Central  Google Scholar 

  12. Cotté F-E, Fardellone P, Mercier F et al (2010) Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 21:145–155. https://doi.org/10.1007/s00198-009-0930-1

    Article  CAS  Google Scholar 

  13. Freiberger E, Kemmler W, Siegrist M, Sieber C (2016) Frailty and exercise interventions : evidence and barriers for exercise programs. Z Gerontol Geriatr 49:606–611. https://doi.org/10.1007/s00391-016-1134-x

    Article  CAS  PubMed  Google Scholar 

  14. Weaver J, Sajjan S, Lewiecki EM, Harris ST (2017) Diagnosis and treatment of osteoporosis before and after fracture: a side-by-side analysis of commercially insured and medicare advantage osteoporosis patients. J Manag Care Spec Pharm 23:735–744. https://doi.org/10.18553/jmcp.2017.23.7.735

    Article  PubMed  Google Scholar 

  15. Yeam CT, Chia S, Tan HCC et al (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int 29:2623–2637. https://doi.org/10.1007/s00198-018-4759-3

    Article  CAS  PubMed  Google Scholar 

  16. Schousboe JT (2013) Adherence with medications used to treat osteoporosis: behavioral insights. Curr Osteoporos Rep 11:21–29. https://doi.org/10.1007/s11914-013-0133-8

    Article  PubMed  Google Scholar 

  17. Clark EM, Gould VC, Tobias JH, Horne R (2016) Natural history, reasons for, and impact of low/non-adherence to medications for osteoporosis in a cohort of community-dwelling older women already established on medication: a 2-year follow-up study. Osteoporos Int 27:579–590. https://doi.org/10.1007/s00198-015-3271-2

    Article  CAS  PubMed  Google Scholar 

  18. Besser SJ, Anderson JE, Weinman J (2012) How do osteoporosis patients perceive their illness and treatment? Implications for clinical practice. Arch Osteoporos 7:115–124. https://doi.org/10.1007/s11657-012-0089-9

    Article  PubMed  Google Scholar 

  19. Alami S, Hervouet L, Poiraudeau S et al (2016) Barriers to effective postmenopausal osteoporosis treatment: a qualitative study of patients’ and practitioners’ views. PLoS ONE 11:e0158365. https://doi.org/10.1371/journal.pone.0158365

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Lau E, Papaioannou A, Dolovich L et al (2008) Patients’ adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women. Can Fam Phys Med Fam Can 54:394–402

    Google Scholar 

  21. Salter C, McDaid L, Bhattacharya D et al (2014) Abandoned acid? Understanding adherence to bisphosphonate medications for the prevention of osteoporosis among older women: a qualitative longitudinal study. PLoS ONE 9:e83552. https://doi.org/10.1371/journal.pone.0083552

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Giangregorio L, Dolovich L, Cranney A et al (2009) Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Educ Couns 74:213–220. https://doi.org/10.1016/j.pec.2008.08.001

    Article  PubMed  Google Scholar 

  23. Mazor KM, Velten S, Andrade SE, Yood RA (2010) Older womenʼs views about prescription osteoporosis medication: a cross-sectional, qualitative study. Drugs Aging 27:999–1008. https://doi.org/10.2165/11584790-000000000-00000

    Article  PubMed  Google Scholar 

  24. Barker KL, Toye F, Lowe CJM (2016) A qualitative systematic review of patients’ experience of osteoporosis using meta-ethnography. Arch Osteoporos. https://doi.org/10.1007/s11657-016-0286-z

    Article  PubMed  PubMed Central  Google Scholar 

  25. Nielsen DS, Brixen K, Huniche L (2011) Men’s experiences of living with osteoporosis: focus group interviews. Am J Mens Health 5:166–176

    Article  PubMed  Google Scholar 

  26. Solimeo SL (2011) Living with a ‘women’s disease’: risk appraisal and management among men with osteoporosis. J Mens Health 8:185–191. https://doi.org/10.1016/j.jomh.2011.06.001

    Article  PubMed  PubMed Central  Google Scholar 

  27. Merle B, Dupraz C, Haesebaert J et al (2018) Osteoporosis prevention: where are the barriers to improvement in a French general population? A qualitative study. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. https://doi.org/10.1007/s00198-018-4720-5

    Article  Google Scholar 

  28. Wong CP, Lok MK, Wun YT, Pang SM (2014) Chinese men’s knowledge and risk factors of osteoporosis: compared with women’s. Am J Mens Health 8:159–166. https://doi.org/10.1177/1557988313503981

    Article  PubMed  Google Scholar 

  29. Babatunde OT, Marquez S, Taylor A (2017) Osteoporosis knowledge and health beliefs among men in midlife years. J Nutr Educ Behav 49:759–763.e1. https://doi.org/10.1016/j.jneb.2017.05.346

    Article  PubMed  Google Scholar 

  30. Hsieh E, Fraenkel L, Bradley EH et al (2014) Osteoporosis knowledge, self-efficacy, and health beliefs among Chinese individuals with HIV. Arch Osteoporos. https://doi.org/10.1007/s11657-014-0201-4

    Article  PubMed  PubMed Central  Google Scholar 

  31. Lassemillante A-CM, Skinner TL, Hooper JD et al (2017) Osteoporosis-related health behaviors in men with prostate cancer and survivors: exploring osteoporosis knowledge, health beliefs, and self-efficacy. Am J Mens Health 11:13–23. https://doi.org/10.1177/1557988315615956

    Article  PubMed  Google Scholar 

  32. Solomon DH, Iversen MD, Avorn J et al (2012) Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med 172:477–483. https://doi.org/10.1001/archinternmed.2011.1977

    Article  PubMed  PubMed Central  Google Scholar 

  33. Schousboe JT, Debold RC, Kuno LS et al (2005) Education and phone follow-up in postmenopausal women at risk for osteoporosis: effects on calcium intake, exercise frequency, and medication use. Dis Manag Health Outcomes 13:395–404

    Article  Google Scholar 

  34. Clowes JA, Peel NFA, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89:1117–1123. https://doi.org/10.1210/jc.2003-030501

    Article  CAS  PubMed  Google Scholar 

  35. Jeihooni AK, Hidarnia A, Kaveh MH et al (2015) Effects of an osteoporosis prevention program based on health belief model among females. Nurs Midwifery Stud 4:e26731. https://doi.org/10.17795/nmsjournal26731

    Article  PubMed  PubMed Central  Google Scholar 

  36. Nielsen D, Ryg J, Nielsen W et al (2010) Patient education in groups increases knowledge of osteoporosis and adherence to treatment: a two-year randomized controlled trial. Patient Educ Couns 81:155–160. https://doi.org/10.1016/j.pec.2010.03.010

    Article  PubMed  Google Scholar 

  37. WHO Working Group (2010) Therapeutic patient education continuing education programmes for health care providers in the field of prevention of chronic diseases. Report of a WHO Working Group 1998. http://www.euro.who.int/document/e63674.pdf. Accessed 29 Mar 2010

  38. Raybould G, Babatunde O, Evans AL et al (2018) Expressed information needs of patients with osteoporosis and/or fragility fractures: a systematic review. Arch Osteoporos. https://doi.org/10.1007/s11657-018-0470-4

    Article  PubMed  PubMed Central  Google Scholar 

  39. Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care J Int Soc Qual Health Care 19:349–357. https://doi.org/10.1093/intqhc/mzm042

    Article  Google Scholar 

  40. Sale JEM, Gignac MA, Frankel L et al (2012) Patients reject the concept of fragility fracture—a new understanding based on fracture patients’ communication. Osteoporos Int 23:2829–2834. https://doi.org/10.1007/s00198-012-1914-0

    Article  CAS  PubMed  Google Scholar 

  41. Siris ES, Gehlbach S, Adachi JD et al (2011) Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). OsteoporosInt 22:27–35

    Article  CAS  Google Scholar 

  42. Roux C, Wyman A, Hooven FH et al (2012) Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 23:2863–2871. https://doi.org/10.1007/s00198-012-1935-8

    Article  CAS  Google Scholar 

  43. Tory HO, Solomon DH, Desai SP (2015) Analysis of quality improvement efforts in preventing glucocorticoid-induced osteoporosis. Semin Arthritis Rheum 44:483–488. https://doi.org/10.1016/j.semarthrit.2014.09.011

    Article  CAS  PubMed  Google Scholar 

  44. Winzenberg T, Oldenburg B, Jones G (2010) Bone density testing: an under-utilised and under-researched health education tool for osteoporosis prevention? Nutrients 2:985–996. https://doi.org/10.3390/nu2090985

    Article  PubMed  PubMed Central  Google Scholar 

  45. Sale JEM, Gignac MA, Hawker G et al (2014) Non-pharmacological strategies used by patients at high risk for future fracture to manage fracture risk—a qualitative study. Osteoporos Int 25:281–288. https://doi.org/10.1007/s00198-013-2405-7

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the patients who participated in the study and all members of the SOLID’OS group.

Members of the SOLID’OS group: rheumatologists: C. Beauvais, B. Cortet, L. Euller Ziegler, E. Lespessailles, F. Levy Weil, D.Poivret, AC Rat, M. Rousière, C. Thévenot, P. Grandhaye; Nurses: D. Aubraye, M. Beranger, F. Nominé; patients association: AFLAR: C. Cardon, L. Carton; occupational therapist: N. Dechassat; dietician: A.Hector.

Funding

This study was funded by the French Society of Rheumatology (SFR). The SFR received an unrestricted institutional grant from Amgen and Lilly for research in the field of osteoporosis and education. Lilly and Amgen were informed that part of the funding would be allocated to this study. Lilly and Amgen did not intervene in the choice of the study’s subject, design, data collection or decision to publish. The grant was used to pay the researchers. All other authors did not receive any honoraria for this study and have no disclosure of interest.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

CB and ACR designed the study, analysed the data and prepared the first and final draft of the paper. They are guarantors. Authors DP, EL, CT, LEZ and MB and FL-W participated in the study design and protocol. Authors DP, EL, CT, LEZ, MR, BC and ACR contributed to the experimental work by selecting patients and collecting data. Authors SG, KL, YM performed the interviews and qualitative analysis. BC reviewed the first and final draft of the paper. All authors revised the paper critically for intellectual content and approved the final version. All authors agree to be accountable for the work and to ensure that any questions relating to the accuracy and integrity of the paper are investigated and properly resolved.

Corresponding author

Correspondence to Catherine Beauvais.

Ethics declarations

Conflict of interest

Catherine Beauvais, Didier Poivret, Eric Lespessailles, Yves Magar, Corinne Thevenot, Liana Euller Ziegler, Sophie Gendarme, Karine Legrand, Edith Filaire, Dominique Aubraye, Martine Beranger, Mickael Rousière, Florence Lévy-Weil, Bernard Cortet, Anne Christine Rat declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

Participants were informed of the study objectives and schedule of the study. Informed consent was obtained from all individual participants included in the study according to local recommendations on research involving human participants.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The members of the SOLID’OS Working Group are listed in the acknowledgments.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beauvais, C., Poivret, D., Lespessailles, E. et al. Understanding Patients’ Perspectives and Educational Needs by Type of Osteoporosis in Men and Women and People with Glucocorticosteroid-Induced Osteoporosis: A Qualitative Study to Improve Disease Management. Calcif Tissue Int 105, 589–608 (2019). https://doi.org/10.1007/s00223-019-00607-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-019-00607-z

Keywords

Navigation